nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—TLR4—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.0923	0.0923	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0476	0.0476	CbGpPWpGaD
Naloxone—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0459	0.0459	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—BCL2L11—sclerosing cholangitis	0.0417	0.0417	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0417	0.0417	CbGpPWpGaD
Naloxone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0384	0.0384	CbGpPWpGaD
Naloxone—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.0377	0.0377	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0353	0.0353	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.0322	0.0322	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.0305	0.0305	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0296	0.0296	CbGpPWpGaD
Naloxone—CREB1—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.0281	0.0281	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—BCL2L11—sclerosing cholangitis	0.0273	0.0273	CbGpPWpGaD
Naloxone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0237	0.0237	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.0234	0.0234	CbGpPWpGaD
Naloxone—CREB1—Circadian Clock—HIF1A—sclerosing cholangitis	0.0215	0.0215	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.0207	0.0207	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0194	0.0194	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.0188	0.0188	CbGpPWpGaD
Naloxone—CREB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.0186	0.0186	CbGpPWpGaD
Naloxone—CREB1—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.0185	0.0185	CbGpPWpGaD
Naloxone—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.0184	0.0184	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—HIF1A—sclerosing cholangitis	0.0178	0.0178	CbGpPWpGaD
Naloxone—CREB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.0169	0.0169	CbGpPWpGaD
Naloxone—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.0155	0.0155	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0135	0.0135	CbGpPWpGaD
Naloxone—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0133	0.0133	CbGpPWpGaD
Naloxone—CREB1—Signaling by NOTCH—HIF1A—sclerosing cholangitis	0.0125	0.0125	CbGpPWpGaD
Naloxone—ESR1—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.0121	0.0121	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—HIF1A—sclerosing cholangitis	0.0116	0.0116	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.0112	0.0112	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—HIF1A—sclerosing cholangitis	0.0108	0.0108	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0103	0.0103	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00942	0.00942	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00935	0.00935	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.0084	0.0084	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TCF4—sclerosing cholangitis	0.0084	0.0084	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00694	0.00694	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00645	0.00645	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00587	0.00587	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00548	0.00548	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.00494	0.00494	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.0048	0.0048	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00463	0.00463	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0046	0.0046	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ABCB4—sclerosing cholangitis	0.0042	0.0042	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00386	0.00386	CbGpPWpGaD
Naloxone—CREB1—Disease—GOT2—sclerosing cholangitis	0.00294	0.00294	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00291	0.00291	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.0029	0.0029	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.00265	0.00265	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00254	0.00254	CbGpPWpGaD
Naloxone—CREB1—Disease—GOT1—sclerosing cholangitis	0.00254	0.00254	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00215	0.00215	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.00206	0.00206	CbGpPWpGaD
Naloxone—ALB—Metabolism—ABCB4—sclerosing cholangitis	0.00205	0.00205	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GOT2—sclerosing cholangitis	0.00199	0.00199	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.0019	0.0019	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.0019	0.0019	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00189	0.00189	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.0018	0.0018	CbGpPWpGaD
Naloxone—CREB1—Disease—HIF1A—sclerosing cholangitis	0.00177	0.00177	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GOT1—sclerosing cholangitis	0.00172	0.00172	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GGT1—sclerosing cholangitis	0.00172	0.00172	CbGpPWpGaD
Naloxone—CREB1—Disease—NOS2—sclerosing cholangitis	0.00161	0.00161	CbGpPWpGaD
Naloxone—ALB—Hemostasis—NOS2—sclerosing cholangitis	0.00131	0.00131	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00124	0.00124	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00123	0.00123	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.00111	0.00111	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00108	0.00108	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	0.00098	0.00098	CbGpPWpGaD
Naloxone—ALB—Metabolism—GOT2—sclerosing cholangitis	0.000974	0.000974	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000913	0.000913	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000853	0.000853	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	0.000846	0.000846	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	0.000846	0.000846	CbGpPWpGaD
Naloxone—ALB—Metabolism—GOT1—sclerosing cholangitis	0.000841	0.000841	CbGpPWpGaD
Naloxone—ALB—Metabolism—GGT1—sclerosing cholangitis	0.000841	0.000841	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00081	0.00081	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GGT1—sclerosing cholangitis	0.000737	0.000737	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GOT1—sclerosing cholangitis	0.000737	0.000737	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	0.000526	0.000526	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	0.000454	0.000454	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	0.000454	0.000454	CbGpPWpGaD
